Cargando…
Scientific discrepancies in European regulatory proposals on endocrine disruptors—REACH regulation quo vadis?
The EU chemical strategy for sustainability places a high focus on endocrine-disrupting chemicals (ED), the importance of their identification with increased testing and a ban in consumer products by a generic approach. It is assumed that for ED no threshold and hence no safe dose exists, leading to...
Autor principal: | Natsch, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492591/ https://www.ncbi.nlm.nih.gov/pubmed/34505931 http://dx.doi.org/10.1007/s00204-021-03152-7 |
Ejemplares similares
-
The EU chemicals strategy for sustainability: critical reflections on proposed regulatory changes for endocrine disruptors and mixture toxicity
por: Batke, M., et al.
Publicado: (2022) -
Rheumatologie – quo vadis? Gesundheitssystem – quo vadis?
por: Puchner, Rudolf
Publicado: (2023) -
Issue analysis: key characteristics approach for identifying endocrine disruptors
por: Borgert, Christopher J.
Publicado: (2023) -
Quo Vadis, Chirurgia Cardiaca?
por: Göbölös, Laszlo, et al.
Publicado: (2021) -
Quo vadis?
por: Sienkiewicz, Henryk, 1846-1916
Publicado: (1943)